How treating sleep apnea could fight against Parkinson’s

How treating sleep apnea could fight against Parkinson’s

Publication date: Mar 24, 2025

However, determining the direction of this relationship has proven challenging. Does sleep apnea increase the risk of developing Parkinsons disease? Studies have found that approximately 40% of Parkinsons patients also have sleep apnea, a rate significantly higher than in the general population. For the millions living with undiagnosed or untreated sleep apnea, this represents a compelling reason to seek help. Studies have found associations between sleep apnea and various forms of cognitive decline, including dementia. Approximately 30 million Americans are estimated to have OSA a condition where breathing repeatedly stops and starts during sleep but only about 6 million have received an official diagnosis. Sleep fragmentation often leads to daytime fatigue, mood disorders, and decreased quality of life. Many patients report difficulties with concentration, memory problems, and reduced work performance. Overcoming treatment challengesDespite the clear benefits of CPAP therapy, many patients struggle with adherence.

Concepts Keywords
Americas Apnea
Healthcare Brain
Overweight Cpap
Parkinsons Diagnosis
Snoring Disease
Mask
Night
Osa
Oxygen
Parkinsons
Risk
Sleep
Suggests
Therapy
Treatment

Semantics

Type Source Name
disease MESH sleep apnea
disease MESH sleep quality
disease MESH obstructive sleep apnea
disease MESH sleep disorders
drug DRUGBANK Oxygen
drug DRUGBANK Medical air
disease MESH excessive daytime sleepiness
disease MESH overweight
disease MESH sleep fragmentation
disease MESH neuroinflammation
disease MESH oxidative stress
disease MESH type 2 diabetes
pathway REACTOME Glucose metabolism
disease MESH insulin sensitivity
disease MESH Cardiovascular risks
disease MESH high blood pressure
disease MESH heart attacks
disease MESH strokes
disease MESH cognitive decline
disease MESH dementia
disease MESH mood disorders
disease MESH work performance
disease MESH Weight loss
disease MESH choking
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
drug DRUGBANK Tropicamide

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *